| FFNS 110 mcg QD (N=53) | Placebo (N=49) | ||||
|---|---|---|---|---|---|
| Baseline | Endpoint | Baseline | Endpoint | ||
| Mean (SD) | 14.2 (22.04) | 5.7 (14.30) | 14.9 (22.03) | 12.0 (22.42) | |
| Median | 4.0 | 0.0 | 2.5 | 0.5 | |
| Minimum - Maximum | 0 – 84 | 0 – 70 | 0 – 87 | 0 – 97 | |
| n (%) | |||||
| <5% | 29 (55) | 44 (83) | 28 (57) | 30 (61) | |
| 5% - <10% | 4 (8) | 1 (2) | 2 (4) | 4 (8) | |
| 10% - <15% | 5 (9) | 2 (4) | 2 (4) | 3 (6) | |
| 15% - <20% | 3 (6) | 1 (2) | 2 (4) | 3 (6) | |
| ≥20% | 12 (23) | 5 (9) | 15 (31) | 9 (18) | |